問卷

TPIDB > Principal Investigator

Principal Investigator


China Medical University Hospital

Division of Radiation Therapy

更新時間:2025-10-18

王耀慶醫師
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

1Cases

2017-01-18 - 2020-04-30

Phase III

Completed
A Randomized, Multicenter, Double Blind, Phase III Study of Nivolumab or Placebo in Subjects with Resected Lower Esophageal, or Gastroesophageal Junction Cancer
  • Condition/Disease

    Resected Esophageal, or Gastroesophageal Junction Cancer

  • Test Drug

    Nivolumab

Participate Sites
4Sites

Terminated3Sites